denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Blood Journals Studio
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Clinical Research, Diversity, Equity, and Inclusion (DEI)
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Clinical Research, Diversity, Equity, and Inclusion (DEI)
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Halls G-H - Blood Journals Studio
(San Diego Convention Center)
Moderator:
and
Christopher R. Flowers, MD, MS, The University of Texas MD Anderson Cancer Center
Disclosures:
Flowers: Denovo Biopharma: Consultancy; BeiGene: Consultancy; AbbVie: Consultancy, Research Funding; Celgene: Consultancy, Research Funding; Bayer: Consultancy, Research Funding; Spectrum: Consultancy; Pharmacyclics / Janssen: Consultancy; N-Power Medicine: Consultancy, Current holder of stock options in a privately-held company; Karyopharm: Consultancy; Gilead: Consultancy, Research Funding; Genmab: Consultancy; Genentech/Roche: Consultancy, Research Funding; Foresight Diagnostics: Consultancy, Current holder of stock options in a privately-held company; Seagen: Consultancy; 4D: Research Funding; Acerta: Research Funding; Adaptimmune: Research Funding; Allogene: Research Funding; Amgen: Research Funding; Cellectis: Research Funding; Guardant: Research Funding; Iovance: Research Funding; Janssen Pharmaceuticals: Research Funding; Kite: Research Funding; Morphosys: Research Funding; Nektar: Research Funding; Novartis: Research Funding; Pfizer: Research Funding; Pharmacyclics: Research Funding; Sanofi: Research Funding; Takeda: Research Funding; TG Therapeutics: Research Funding; Xencor: Research Funding; Ziopharm National Cancer Institute: Research Funding; Burroughs Wellcome Fund: Research Funding; Eastern Cooperative Oncology Group: Research Funding; BostonGene: Research Funding; EMD Serono: Research Funding; Cancer Prevention and Research Institute of Texas: CPRIT Scholar in Cancer Research: Research Funding; AstraZeneca: Consultancy; Bio Ascend: Consultancy; Bristol Myers Squibb: Consultancy.
This event will honor the research of this year's Distinguished Abstract Achievement Award winners, including our partnered awards and the Outstanding Abstract Achievement Award which recognizes the top scoring abstracts in each trainee category (undergraduate, graduate, medical student, resident, and post-doctoral fellow). This event will be moderated by Dr. Christopher Flowers.
The list of 2024 Winners are:
Yu Akahoshi
Hussein Awada
Francesca Cendali
Alejandro De Janon
Daisy Diaz Rohena
Enrica Federti
Mike Fernandez
Travis Fleming
Natalie Grover
Fernanda Gutierrez-Rodrigues
Amelia Haj
NaShea Kendrick
Kristopher Knight
Luca Lanino
Olivia Lightfuss
Shan Liu
Paola Manara
Alicia Matthews
Aneta Mikulasova
Adrian Minson
Toru Miyajima
Daniel Navarrete
Maria Feliz Norberto
Jenny Paredes
Alexandros Rampotas
Suruchi Salgar
Ruka Shimura
Samuel Urrutia
Joshua Wischmeyer
Casey Wong
Xuesen Zheng
See more of: Blood Journals Studio